NetworkNewsBreaks – AnPac Bio-Medical Science Co
Post# of 61
AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced that it is starting an underwritten public offering; the offering is comprised of ANPC’s American Depositary Shares and is subject to market and other conditions. The announcement noted that there is no assurance regarding when the offering may be completed, what the size of the offering is or terms of the offering. The company is providing copies of the prospectus supplement and other material relating to the offering.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer